Takeda sets vote date, aims to close $62 billion Shire deal Jan. 8

Japan's Takeda Pharmaceutical will hold an investor vote on its $62 billion acquisition of Shire next month and aims to close the deal on Jan. 8, signaling its confidence in securing the required support.